3SBio (SSRX) Announces Nephoxil Marketing and Development Collaboration
Tweet Send to a Friend
3SBio Inc. (NASDAQ: SSRX) today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


